Dr. Grant Hatch
Grant M. Hatch, PhD 
Professor - Departments of Pharmacology and Therapeutics & Biochemistry and Medical Genetics
Canada Research Chair in Molecular Cardiolipin Metabolism
Director of the Lipid Lipoprotein and Atherosclerosis Research Group (LLARG)
Director of the  Centre for Research and Treatment of Atherosclerosis
Co-Director of the Diabetes Research Envisioned and Accomplished in Manitioba (DREAM) Theme
501C Jonh Bhuler Research Center
715 McDermot Avenue, Winnipeg, MB R3E 3P4
(204) 789-3405  
ghatch@chrim.ca
PubMed

 

 

Research Focus:
My research interests focus upon three main areas in whole animal, organ, cellular and molecular biology.

Area 1. Biology of Cardiolipin
In my research program we are examining the regulation of the metabolism of the polyglycerophospholipid bis-(1,2-diacyl-sn-glycero-3-phospho)-1',3'-sn-glycerol (or cardiolipin, Abbreviated CL). CL comprises approximately 20% of the entire phospholipid phosphorus composition of the heart, the highest of all mammalian tissues. Specifically we are studying the regulation of CL biosynthesis and remodeling in the heart and in mammalian tissues and cells.

Area 2. Biology of Human Lipid Disorders
Barth Syndrome is a rare X-linked genetic disorder in young boys and is the only known genetic disease in which the specific biochemical defect is a reduction in cardiolipin (CL) and an accumulation of monolysoCL. The causative gene, TAZ, gives rise to tafazzins which are phospholipid. Although over 100 mutations in TAZ have been described in patients, no single mutation is concordant with the disease. A reduced ability to remodel CL is the underlying molecular mechanism responsible for the Barth Syndrome. The role that TAZ plays in CL metabolism and Barth Syndrome is an active area of investigation in the laboratory.
Type 2 diabetes and obesity have become major health concerns over the past twenty years. The role that CL plays in the development of diabetes and obesity is an active area of investigation in the laboratory. In addition, we are examining the role of nutritional interventions in the management of these disorders.

Area 3. Biology of the Blood Brain Barrier
The blood-brain barrier formed by the brain capillary endothelial cells provides a protective barrier between the systemic blood and the extracellular environment of the central nervous system. We are examining the mechanisms that govern transport across primary human brain microvessel endothelial cells (HBMEC).

Newest Awards:
National Sciences and Engineering Research Council Discovery Grant (2014-2019)
Heart and Stroke Foundation of Canada Operating Grant (2014-17)
Canada Research Chair in Molecular Cardiolipin Metabolism (2013-20)
Canadian Institutes of Health Research Operating Grant (2010-15)
Barth Syndrome Foundation of Canada and USA Inc. Operating Grant (2014-15)


Publications: PubMed

More information on Dr. Grant Hatch can be found at www.mich.ca/research/grant-hatch/

 

 

 

 

 

 

 

   
Dr. Grant M. Hatch
Area of research:  Lipid metabolism, Cardiolipin

Newest Awards:
National Sciences and Engineering Research Council Discovery Grant (2014-2019)
Heart and Stroke Foundation of Canada Operating Grant (2017-20)
Canada Research Chair in Molecular Cardiolipin Metabolism (2013-20)